- Home
- KTTA vs XXII Comparison
KTTA vs XXII Comparison
Compare KTTA & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- XXII
- Stock Information
- Founded
- KTTA 2020
- XXII 1998
- Country
- KTTA United States
- XXII United States
- Employees
- KTTA N/A
- XXII N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- XXII Medicinal Chemicals and Botanical Products
- Sector
- KTTA Health Care
- XXII Health Care
- Exchange
- KTTA Nasdaq
- XXII Nasdaq
- Market Cap
- KTTA 2.6M
- XXII 2.8M
- IPO Year
- KTTA 2021
- XXII N/A
- Fundamental
- Price
- KTTA $1.30
- XXII $3.15
- Analyst Decision
- KTTA
- XXII
- Analyst Count
- KTTA 0
- XXII 0
- Target Price
- KTTA N/A
- XXII N/A
- AVG Volume (30 Days)
- KTTA 3.3M
- XXII 166.3K
- Earning Date
- KTTA 03-28-2025
- XXII 03-27-2025
- Dividend Yield
- KTTA N/A
- XXII N/A
- EPS Growth
- KTTA N/A
- XXII N/A
- EPS
- KTTA N/A
- XXII N/A
- Revenue
- KTTA N/A
- XXII $17,304,000.00
- Revenue This Year
- KTTA N/A
- XXII $56.94
- Revenue Next Year
- KTTA N/A
- XXII $2.98
- P/E Ratio
- KTTA N/A
- XXII N/A
- Revenue Growth
- KTTA N/A
- XXII N/A
- 52 Week Low
- KTTA $1.25
- XXII $3.01
- 52 Week High
- KTTA $9.25
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- KTTA 30.34
- XXII 35.94
- Support Level
- KTTA $1.32
- XXII $3.01
- Resistance Level
- KTTA $1.38
- XXII $3.47
- Average True Range (ATR)
- KTTA 0.26
- XXII 0.33
- MACD
- KTTA -0.05
- XXII 0.11
- Stochastic Oscillator
- KTTA 1.92
- XXII 11.29
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.